Annual report [Section 13 and 15(d), not S-K Item 405]

Restatement of Previously Issued Financial Statements - Schedule of Consolidated Statements of Cash Flows (Details)

v3.25.1
Restatement of Previously Issued Financial Statements - Schedule of Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Condensed Cash Flow Statements, Captions [Line Items]      
Net loss $ (102,818) $ (77,558)  
Other, net 301 505  
Change in contract assets 3,119 (1,647)  
Other current assets 12,445 (9,803)  
Change in contract liabilities 2,748 13,693  
Other accrued expenses 7,136 (1,116)  
Net Cash used in operating activities (18,453) (36,307)  
Purchase of property and equipment (26,581) (17,352)  
Net cash used in investing activities (14,231) (4,968)  
Cash, cash equivalents and restricted cash - Ending balance $ 19,684 $ 29,633 $ 47,569